176 related articles for article (PubMed ID: 11907945)
41. Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy.
Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Genazzani AR
Maturitas; 2003 Jul; 45(3):175-83. PubMed ID: 12818462
[TBL] [Abstract][Full Text] [Related]
42. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women.
Castelo-Branco C; Vicente JJ; Figueras F; Sanjuan A; Martínez de Osaba MJ; Casals E; Pons F; Balasch J; Vanrell JA
Maturitas; 2000 Feb; 34(2):161-8. PubMed ID: 10714911
[TBL] [Abstract][Full Text] [Related]
43. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
Reginster JY
J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
[TBL] [Abstract][Full Text] [Related]
44. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
45. Effect of hormone replacement therapy and calcitonin on bone mass in postmenopausal women.
Meschia M; Brincat M; Barbacini P; Maini MC; Marri R; Crosignani PG
Eur J Obstet Gynecol Reprod Biol; 1992 Oct; 47(1):53-7. PubMed ID: 1330761
[TBL] [Abstract][Full Text] [Related]
46. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
[TBL] [Abstract][Full Text] [Related]
47. The effect of low-dose conjugated equine estrogens and cyclic MPA on bone density.
Gass M; Liu J; Rebar RW
Maturitas; 2002 Feb; 41(2):143-7. PubMed ID: 11836045
[TBL] [Abstract][Full Text] [Related]
48. HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women.
Heikkinen J; Kyllönen E; Kurttila-Matero E; Wilén-Rosenqvist G; Lankinen KS; Rita H; Väänänen HK
Maturitas; 1997 Mar; 26(2):139-49. PubMed ID: 9089564
[TBL] [Abstract][Full Text] [Related]
49. The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.
Skouby SO; Sidelmann JJ; Nilas L; Gram J; Jespersen J
Climacteric; 2008; 11(6):489-97. PubMed ID: 18991076
[TBL] [Abstract][Full Text] [Related]
50. Effects of tibolone and conventional hormone replacement therapies on arterial and hepatic cholesterol accumulation and on circulating endothelin-1, vascular cell adhesion molecule-1, and E-selectin in surgically menopausal monkeys.
Register TC; Wagner JD; Zhang L; Hall J; Clarkson TB
Menopause; 2002; 9(6):411-21. PubMed ID: 12439100
[TBL] [Abstract][Full Text] [Related]
51. A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women.
Prestwood KM; Gunness M; Muchmore DB; Lu Y; Wong M; Raisz LG
J Clin Endocrinol Metab; 2000 Jun; 85(6):2197-202. PubMed ID: 10852452
[TBL] [Abstract][Full Text] [Related]
52. Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/progestin therapy: a 2-year prospective study.
Mizunuma H; Okano H; Soda M; Kagami I; Miyamoto S; Tokizawa T; Honjo S; Ibuki Y
Maturitas; 1997 May; 27(1):69-76. PubMed ID: 9158080
[TBL] [Abstract][Full Text] [Related]
53. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
[TBL] [Abstract][Full Text] [Related]
54. Bone protection for early menopausal women in China: standard or half-dose estrogen with progestin? A one-year prospective randomized trail.
Zhu SY; Deng Y; Wang YF; Xue W; Ma X; Sun A
Gynecol Endocrinol; 2019 Feb; 35(2):165-169. PubMed ID: 30449208
[TBL] [Abstract][Full Text] [Related]
55. A randomized study of tibolone on bone mineral density in osteoporotic postmenopausal women with previous fractures.
Studd J; Arnala I; Kicovic PM; Zamblera D; Kröger H; Holland N
Obstet Gynecol; 1998 Oct; 92(4 Pt 1):574-9. PubMed ID: 9764631
[TBL] [Abstract][Full Text] [Related]
56. Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women.
Delmas PD; Davis SR; Hensen J; Adami S; van Os S; Nijland EA
Osteoporos Int; 2008 Aug; 19(8):1153-60. PubMed ID: 18256777
[TBL] [Abstract][Full Text] [Related]
57. Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies.
Gallagher JC; Baylink DJ; Freeman R; McClung M
J Clin Endocrinol Metab; 2001 Oct; 86(10):4717-26. PubMed ID: 11600531
[TBL] [Abstract][Full Text] [Related]
58. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
[TBL] [Abstract][Full Text] [Related]
59. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
60. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.
Wu MH; Pan HA; Wang ST; Hsu CC; Chang FM; Huang KE
Climacteric; 2001 Dec; 4(4):314-9. PubMed ID: 11770188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
